CTMX
Price
$2.00
Change
-$0.05 (-2.44%)
Updated
Aug 29, 02:04 PM (EDT)
Capitalization
338.07M
69 days until earnings call
KZR
Price
$3.93
Change
-$0.04 (-1.01%)
Updated
Aug 29, 12:10 PM (EDT)
Capitalization
29M
Interact to see
Advertisement

CTMX vs KZR

Header iconCTMX vs KZR Comparison
Open Charts CTMX vs KZRBanner chart's image
CytomX Therapeutics
Price$2.00
Change-$0.05 (-2.44%)
Volume$1.12K
Capitalization338.07M
Kezar Life Sciences
Price$3.93
Change-$0.04 (-1.01%)
Volume$200
Capitalization29M
CTMX vs KZR Comparison Chart in %
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. KZR commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Hold and KZR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (CTMX: $2.05 vs. KZR: $3.97)
Brand notoriety: CTMX and KZR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 43% vs. KZR: 36%
Market capitalization -- CTMX: $338.07M vs. KZR: $29M
CTMX [@Biotechnology] is valued at $338.07M. KZR’s [@Biotechnology] market capitalization is $29M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 0 FA rating(s) are green whileKZR’s FA Score has 1 green FA rating(s).

  • CTMX’s FA Score: 0 green, 5 red.
  • KZR’s FA Score: 1 green, 4 red.
According to our system of comparison, CTMX is a better buy in the long-term than KZR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 6 TA indicator(s) are bullish while KZR’s TA Score has 4 bullish TA indicator(s).

  • CTMX’s TA Score: 6 bullish, 4 bearish.
  • KZR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CTMX is a better buy in the short-term than KZR.

Price Growth

CTMX (@Biotechnology) experienced а +0.99% price change this week, while KZR (@Biotechnology) price change was +0.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.00%. For the same industry, the average monthly price growth was +15.19%, and the average quarterly price growth was +29.46%.

Reported Earning Dates

CTMX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-1.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($338M) has a higher market cap than KZR($29M). CTMX YTD gains are higher at: 99.029 vs. KZR (-40.923). CTMX has higher annual earnings (EBITDA): 44.7M vs. KZR (-68.34M). CTMX has more cash in the bank: 158M vs. KZR (101M). CTMX has less debt than KZR: CTMX (6.89M) vs KZR (12.1M). CTMX has higher revenues than KZR: CTMX (141M) vs KZR (0).
CTMXKZRCTMX / KZR
Capitalization338M29M1,166%
EBITDA44.7M-68.34M-65%
Gain YTD99.029-40.923-242%
P/E Ratio4.14N/A-
Revenue141M0-
Total Cash158M101M156%
Total Debt6.89M12.1M57%
FUNDAMENTALS RATINGS
CTMX vs KZR: Fundamental Ratings
CTMX
KZR
OUTLOOK RATING
1..100
687
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3884
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KZR's Valuation (11) in the Biotechnology industry is in the same range as CTMX (38). This means that KZR’s stock grew similarly to CTMX’s over the last 12 months.

KZR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CTMX (100). This means that KZR’s stock grew similarly to CTMX’s over the last 12 months.

KZR's SMR Rating (100) in the Biotechnology industry is in the same range as CTMX (100). This means that KZR’s stock grew similarly to CTMX’s over the last 12 months.

CTMX's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for KZR (84). This means that CTMX’s stock grew somewhat faster than KZR’s over the last 12 months.

CTMX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as KZR (100). This means that CTMX’s stock grew similarly to KZR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTMXKZR
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKBL0.910.09
+10.77%
Skyline Builders Group Holding Ltd
ZJK3.900.25
+6.85%
ZJK Industrial Co Ltd
BNS62.390.66
+1.07%
Bank of Nova Scotia
BOW31.07-0.33
-1.05%
Bowhead Specialty Holdings Inc
IAG8.95-0.21
-2.29%
IAMGold Corp